New pill tested to calm schizophrenia Flare-Ups
Disease control
Completed
This study tested whether a new daily pill called LB-102 could help reduce symptoms in adults hospitalized with a sudden worsening of schizophrenia. About 360 participants were randomly assigned to receive either the drug at different doses or a placebo (a pill with no medicine) …
Phase: PHASE2 • Sponsor: LB Pharmaceuticals Inc. • Aim: Disease control
Last updated Apr 02, 2026 04:11 UTC